What does royalty monetization liabilities current mean?

This represents the portion of financial obligations arising from the monetization of future royalty streams that is due within the next twelve months. It reflects the company's commitment to repay capital providers from anticipated revenue generated by licensed intellectual property or product sales. This metric is critical for evaluating the company's near-term debt service obligations and the impact of financing arrangements on future cash flows.

Regenxbio RGNX Royalty Monetization Liabilities Current

Royalty Monetization Liabilities Current at other companies

Ultragenyx PharmaceuticalRARE

$72M+25.5%

BioCryst PharmaceuticalsBCRX

$40.32M+17.5%

PTC TherapeuticsPTCT

$305.04M+22.9%

GeronGERN

$19.39M+24.8%

MannkindMNKD

$136.56M-0.6%

Syndax PharmaceuticalsSNDX

$343.91M+3.7%

Other financials

Income statement

See full

Revenue$6.4M-92.8%

Gross profit$14.9M+35.7%

Operating income-$83.4M-787%

Net income-$90.1M-1,580%

EPS (diluted)-$1.72-1,533%

Balance sheet

See full

Cash & equivalents$15.2M-88.3%

Total debt$71.1M-11.0%

Total equity$21.1M-92.3%

Total assets$341.9M-30.4%

Cash flow

See full

Operating cash flow-$76.2M-327%

CapEx$1.2M+20.6%

Free cash flow-$77.4M-337%

Valuation

See full

Market cap$529.38M+24.6%

Enterprise value$585.22M+56.3%

P/S6×+3.3×

Profitability

See full

Gross margin59.7%+1.0pp

Operating margin-292.3%-613pp

Net margin-330.2%-588pp

FCF margin-269.2%-364pp

Returns & leverage

See full

Return on equity-196.4%-288pp

Debt / equity3.4×+3.1×

Current ratio2.6×-0.3×

Where this comes from

Reported directly by Regenxbio in its filing.

Tagged under the XBRL concept rgnx:RoyaltyMonetizationLiabilitiesCurrent.

The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regenxbio's royalty monetization liabilities current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Regenxbio's royalty monetization liabilities current?: Regenxbio (RGNX) reported royalty monetization liabilities current of $14.23M in Q1 2026.
What does royalty monetization liabilities current mean?: This represents the portion of financial obligations arising from the monetization of future royalty streams that is due within the next twelve months. It reflects the company's commitment to repay capital providers from anticipated revenue generated by licensed intellectual property or product sales. This metric is critical for evaluating the company's near-term debt service obligations and the impact of financing arrangements on future cash flows.